No-Reflow Phenomenon Clinical Trial
Official title:
Mean Platelet Volume and STEMI Clinical Risk Scores in Prediction of Impaired Myocardial Perfusion In Acute STEMI Patients Undergoing PPCI.
Predicting no reflow in ppci of STEMI patients using mean platelet volume together with STEMI clinical risk scores
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT03264859 -
NGAL and Its Association With the No-reflow Phenomenon in ST-elevation Myocardial Infarction
|
N/A | |
Not yet recruiting |
NCT06342141 -
Empagliflozin for No-reflow Phenomenon in PCI for STEMI
|
Phase 2 | |
Not yet recruiting |
NCT04835974 -
the No-reflow in Diabetic Patients Treated With Primary Percutaneous Coronary Intervention (PCI)
|
N/A | |
Not yet recruiting |
NCT05360602 -
Alpha Lipoic Acid Effect on No-Reflow Phenomenon
|
N/A | |
Completed |
NCT02054000 -
Intracoronary Tirofiban on No-Reflow Phenomena
|
Phase 4 | |
Not yet recruiting |
NCT05393557 -
Upfront Premedication For Reduction of Microvascular Obstruction and No-reflow in Treating ST-segment Elevation Myocardial Infarction
|
N/A | |
Completed |
NCT04699110 -
Adrenaline for the Treatment of No-Reflow in Normotensive Patients
|
Phase 4 | |
Completed |
NCT04573751 -
The EPIVER Randomized Controlled Trial
|
N/A | |
Not yet recruiting |
NCT02233790 -
Ticagrelor and Clopidogrel on Reperfusion in Patients With AMI
|
Phase 4 | |
Recruiting |
NCT05427786 -
A Study to Evaluate the Impact of Pre-procedural Intracoronary Nicorandil Injection to PREVENT reductioN Of decREased TIMI FLOW in Patients Who Undergoing Percutaneous Coronary Intervention for the Coronary Artery Disease
|
Phase 4 | |
Completed |
NCT05355532 -
Genetic Determinants of the Coronary Microvascular Obstruction in PCI
|